Equities Research Analysts’ updated eps estimates for Friday, October 6th:

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its neutral rating reaffirmed by analysts at Goldman Sachs Group, Inc. (The).

Alio Gold (TSE:ALO) had its market perform rating reaffirmed by analysts at BMO Capital Markets. They currently have a C$6.00 target price on the stock.

Amgen (NASDAQ:AMGN) had its buy rating reaffirmed by analysts at Mizuho. The firm currently has a $198.00 price target on the stock.

Arc Logistic Partners (NYSE:ARCX) had its hold rating reiterated by analysts at Stifel Nicolaus. They currently have a $16.50 target price on the stock.

Atara Biotherapeutics (NASDAQ:ATRA) had its neutral rating reiterated by analysts at Goldman Sachs Group, Inc. (The).

Catabasis Pharmaceuticals (NASDAQ:CATB) had its market perform rating reissued by analysts at Cowen and Company. They currently have a $2.00 target price on the stock.

Cogeco (TSE:CGO) was downgraded by analysts at TD Securities from a buy rating to a hold rating. TD Securities currently has C$95.00 target price on the stock.

Civista Bancshares (NASDAQ:CIVB) had its buy rating reaffirmed by analysts at Sandler O’Neill. The firm currently has a $25.00 price target on the stock, up from their previous price target of $23.50.

Corus Entertainment (TSE:CJR.B) had its buy rating reissued by analysts at Desjardins. The firm currently has a C$15.00 target price on the stock.

Canadian National Railway (NYSE:CNI) (TSE:CNR) had its hold rating reissued by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $89.00 target price on the stock.

Electronic Arts (NASDAQ:EA) had its buy rating reiterated by analysts at Stifel Nicolaus. They currently have a $127.00 target price on the stock.

US Ecology (NASDAQ:ECOL) had its buy rating reiterated by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $60.00 target price on the stock.

Scandium International Mining Corp (TSE:EMC) had its buy rating reissued by analysts at Canaccord Genuity. Canaccord Genuity currently has a C$2.25 price target on the stock.

Amicus Therapeutics (NASDAQ:FOLD) had its neutral rating reaffirmed by analysts at Goldman Sachs Group, Inc. (The).

Alphabet (NASDAQ:GOOG) had its outperform rating reissued by analysts at Macquarie. Macquarie currently has a $995.00 price target on the stock.

GW Pharmaceuticals PLC (NASDAQ:GWPH) had its neutral rating reissued by analysts at Goldman Sachs Group, Inc. (The).

Heron Therapeutics (NASDAQ:HRTX) had its buy rating reissued by analysts at Noble Financial. The firm currently has a $24.00 price target on the stock.

International Business Machines Corporation (NYSE:IBM) had its buy rating reiterated by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $182.00 price target on the stock.

Intercept Pharmaceuticals (NASDAQ:ICPT) had its neutral rating reaffirmed by analysts at Goldman Sachs Group, Inc. (The).

Dougherty & Co began coverage on shares of inTEST (NYSEMKT:INTT). Dougherty & Co issued a buy rating and a $11.00 price target on the stock.

Intuit (NASDAQ:INTU) had its hold rating reissued by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $132.00 target price on the stock.

Juno Therapeutics (NASDAQ:JUNO) had its neutral rating reaffirmed by analysts at Goldman Sachs Group, Inc. (The).

Presbia PLC (NASDAQ:LENS) had its buy rating reiterated by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $10.00 target price on the stock, down from their previous target price of $11.00.

Littelfuse (NASDAQ:LFUS) had its hold rating reissued by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $185.00 price target on the stock.

Dougherty & Co initiated coverage on shares of LightPath Technologies (NASDAQ:LPTH). Dougherty & Co issued a buy rating and a $3.10 target price on the stock.

Mallinckrodt PLC (NYSE:MNK) had its buy rating reiterated by analysts at Stifel Nicolaus.

Momenta Pharmaceuticals (NASDAQ:MNTA) was downgraded by analysts at Robert W. Baird from a buy rating to a hold rating. Robert W. Baird currently has $15.00 target price on the stock, down from their previous target price of $22.00.

Netflix (NASDAQ:NFLX) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $210.00 price target on the stock.

Netflix (NASDAQ:NFLX) had its outperform rating reissued by analysts at Wells Fargo & Company.

Netflix (NASDAQ:NFLX) had its underperform rating reissued by analysts at Wedbush. The firm currently has a $82.00 target price on the stock, down from their previous target price of $88.00.

Oclaro (NASDAQ:OCLR) had its buy rating reaffirmed by analysts at Stifel Nicolaus. The firm currently has a $12.00 target price on the stock.

Radius Health (NASDAQ:RDUS) had its neutral rating reissued by analysts at Goldman Sachs Group, Inc. (The).

Seattle Genetics (NASDAQ:SGEN) had its neutral rating reissued by analysts at Goldman Sachs Group, Inc. (The).

ServiceSource International (NASDAQ:SREV) had its hold rating reiterated by analysts at Northland Securities. They currently have a $5.25 target price on the stock.

Constellation Brands (NYSE:STZ) had its outperform rating reiterated by analysts at Evercore ISI. The firm currently has a $235.00 price target on the stock, up from their previous price target of $230.00.

Constellation Brands (NYSE:STZ) had its outperform rating reiterated by analysts at Cowen and Company. The firm currently has a $243.00 target price on the stock, up from their previous target price of $230.00.

Trilogy Metals (NYSE:TMQ) had its buy rating reaffirmed by analysts at Fundamental Research. They currently have a $2.15 price target on the stock.

Victoria Gold Corp (CVE:VIT) had its outperform rating reaffirmed by analysts at BMO Capital Markets. They currently have a C$1.00 target price on the stock.

Intrexon Corporation (NYSE:XON) had its buy rating reiterated by analysts at Northland Securities. The firm currently has a $27.00 target price on the stock.

Yum China Holdings (NASDAQ:YUMC) was upgraded by analysts at Deutsche Bank AG from a hold rating to a buy rating.

Receive News & Ratings for ACADIA Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ACADIA Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.